DRUG TARGET ISOGENES: POLYMORPHISMS IN THE 5-HYDROXYTRYPTAMINE RECEPTOR 1A GENE - Patent 1208112

(19)

(11)

EP 1 208 112 A1

(12)

(43)	Date of publication:
	29.05.2002 Bulletin 2002/22

(21)	Application number: 00962018.8

(22)	Date of filing: 01.08.2000

(51)	International Patent Classification (IPC)⁷: C07H 21/04, C07K 14/00, C07K 16/00, C12N 15/00

(86)	International application number:
	PCT/US0040/519

(87)	International publication number:
	WO 0110/884 (15.02.2001 Gazette 2001/07)

(84)	Designated Contracting States:
	AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
	Designated Extension States:
	AL LT LV MK RO SI

(30)

Priority:

06.08.1999 US 147711 P

(71)	Applicant: Genaissance Pharmaceuticals, Inc.
	New Haven, CT 06511 (US)

(72)	Inventors:
	DENTON, R., Rex Madison, CT 06443 (US) KLIEM, Stefanie, E. North Haven, CT 06473 (US) NANDABALAN, Krishnan Guilford, CT 06437 (US) STEPHENS, Joel, Claiborne Guilford, CT 06437 (US)

(74)	Representative: Molnia, David
	Dörries, Frank-Molnia, Pohlman,Postfach 221661 80506 München 80506 München (DE)

(54)	DRUG TARGET ISOGENES: POLYMORPHISMS IN THE 5-HYDROXYTRYPTAMINE RECEPTOR 1A GENE